Menu Search
Equities

Terrascend Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
TED:MUN

Terrascend Corp

Actions
  • Price (EUR)0.505
  • Today's Change0.007 / 1.41%
  • Shares traded3.00k
  • 1 Year change-17.21%
  • Beta2.0375
Data delayed at least 15 minutes, as of Feb 16 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

TerrAscend Corp. is a Canada-based cannabis company. The Company has vertically integrated operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through its subsidiary, TerrAscend Growth Corp., along with retail operations in Canada. The Company operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core market. The Company’s cultivation and production methods deliver cannabis, offerring a diverse range of products for both medical and legal adult-use consumers. It has a variety of product types, including flowers, vaporizable, concentrations, topicals, tinctures, and edibles. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. It also operates a cannabis dispensary located in Goshen Township, Ohio.

  • Revenue in CAD (TTM)375.09m
  • Net income in CAD-87.44m
  • Incorporated2017
  • Employees742.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		TSND:TOR since
announced		Transaction
value
Union Chill Cannabis Co LLCDeal completed06 May 202506 May 2025Deal completed50.91%13.00m
Data delayed at least 15 minutes, as of Feb 13 2026 20:59 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.